{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/039b783b-a527-4fdf-b3ce-b3c255ad3034/6972b736680e40968b51d195?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Brave New World Preview","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba036a1a8cbef5973cf0c0/1769125569223-826c3dde-6f7e-4d0e-8bf6-6988ac9cde60.jpeg?height=200","description":"<p>For episode five of <em>Brave New World</em>, Evgeny is joined by Ben Lamm, CEO and co-founder of Colossal Biosciences - the company working on de-extinction and species preservation, including its flagship woolly mammoth project. Together, they explore what “bringing back” an extinct species actually means in practice: rebuilding fragmented ancient DNA, comparing it to a close living relative (the Asian elephant), and using gene editing to reintroduce key traits like cold tolerance - before creating embryos that could one day be carried by a surrogate or, eventually, an artificial womb.</p><p>Ben also explains why the mammoth has become Colossal’s defining project - from public fascination and unusually strong samples preserved in permafrost, to the potential conservation upside. The conversation dives into how the same tools can support living species too: developing new reproductive technologies, using AI and drones to understand elephant behaviour, and tackling threats like EEHV, a disease that kills young elephants. Along the way, they discuss Colossal’s viral moments - including the woolly mouse and the dire wolf - as well as the ethical lines the company says it won’t cross.</p><p>This episode was produced by Message Heard and The Standard.</p>","author_name":"The Evening Standard"}